BIOMARIN PHARMACEUTICAL INC Basic Shares Outstanding (Weighted Average)
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Basic Shares Outstanding (Weighted Average) of 193.42 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 193.42M shares, a 0.79% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 192.50M shares, a 0.80% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 192.23M shares, a 0.81% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 192.03M shares, a 0.84% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic for fiscal 2025 was 191.79M shares, a 0.93% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic for fiscal 2024 was 190.03M shares, a 1.17% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic for fiscal 2023 was 187.83M shares, a 1.39% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic for fiscal 2022 was 185.27M shares, a 1.32% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 193.42M shares 10-Q · filed 2026-08-06 | 192.96M shares 10-Q · filed 2026-08-06 | 192.72M shares derived: average of 3 quarters · filed 2026-08-06 | 192.55M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 192.50M shares 10-Q · filed 2026-05-05 | 192.36M shares derived: average of 2 quarters · filed 2026-05-05 | 192.25M shares derived: average of 3 quarters · filed 2026-05-05 | 192.17M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 192.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 192.13M shares derived: average of 2 quarters · filed 2026-02-26 | 192.06M shares derived: average of 3 quarters · filed 2026-08-06 | 191.79M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 192.03M shares 10-Q · filed 2025-10-28 | 191.97M shares derived: average of 2 quarters · filed 2026-08-06 | 191.64M shares 10-Q · filed 2025-10-28 | 191.40M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 191.91M shares 10-Q · filed 2026-08-06 | 191.44M shares 10-Q · filed 2026-08-06 | 191.19M shares derived: average of 3 quarters · filed 2026-08-06 | 191.00M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 190.97M shares 10-Q · filed 2026-05-05 | 190.83M shares derived: average of 2 quarters · filed 2026-05-05 | 190.70M shares derived: average of 3 quarters · filed 2026-05-05 | 190.55M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 190.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 190.56M shares derived: average of 2 quarters · filed 2026-02-26 | 190.41M shares derived: average of 3 quarters · filed 2026-02-26 | 190.03M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 190.43M shares 10-Q · filed 2025-10-28 | 190.27M shares derived: average of 2 quarters · filed 2025-10-28 | 189.81M shares 10-Q · filed 2025-10-28 | 189.47M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 190.11M shares 10-Q · filed 2025-08-05 | 189.49M shares 10-Q · filed 2025-08-05 | 189.16M shares derived: average of 3 quarters · filed 2026-02-26 | 188.92M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 188.87M shares 10-Q · filed 2025-05-02 | 188.68M shares derived: average of 2 quarters · filed 2026-02-26 | 188.52M shares derived: average of 3 quarters · filed 2026-02-26 | 188.38M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 188.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 188.35M shares derived: average of 2 quarters · filed 2026-02-26 | 188.22M shares derived: average of 3 quarters · filed 2026-02-26 | 187.83M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 188.22M shares 10-Q · filed 2024-10-31 | 188.08M shares derived: average of 2 quarters · filed 2024-10-31 | 187.62M shares 10-Q · filed 2024-10-31 | 187.22M shares derived: average of 4 quarters · filed 2025-02-24 |
| 2023-06-30 | 187.95M shares 10-Q · filed 2024-08-05 | 187.31M shares 10-Q · filed 2024-08-05 | 186.88M shares derived: average of 3 quarters · filed 2025-02-24 | 186.56M shares derived: average of 4 quarters · filed 2025-02-24 |
| 2023-03-31 | 186.67M shares 10-Q · filed 2024-04-26 | 186.35M shares derived: average of 2 quarters · filed 2025-02-24 | 186.10M shares derived: average of 3 quarters · filed 2025-02-24 | 185.89M shares derived: average of 4 quarters · filed 2025-02-24 |
| 2022-12-31 | 186.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | 185.82M shares derived: average of 2 quarters · filed 2025-02-24 | 185.63M shares derived: average of 3 quarters · filed 2025-02-24 | 185.27M shares 10-K · filed 2025-02-24 |
| 2022-09-30 | 185.60M shares 10-Q · filed 2023-11-02 | 185.43M shares derived: average of 2 quarters · filed 2023-11-02 | 185.01M shares 10-Q · filed 2023-11-02 | 184.60M shares derived: average of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | 185.25M shares 10-Q · filed 2023-08-02 | 184.71M shares 10-Q · filed 2023-08-02 | 184.27M shares derived: average of 3 quarters · filed 2024-02-26 | 184.00M shares derived: average of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | 183.99M shares 10-Q · filed 2023-04-28 | 183.78M shares derived: average of 2 quarters · filed 2024-02-26 | 183.59M shares derived: average of 3 quarters · filed 2024-02-26 | 183.40M shares derived: average of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | 183.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | 183.39M shares derived: average of 2 quarters · filed 2024-02-26 | 183.21M shares derived: average of 3 quarters · filed 2024-02-26 | 182.85M shares 10-K · filed 2024-02-26 |
| 2021-09-30 | 183.21M shares 10-Q · filed 2022-10-28 | 183.03M shares derived: average of 2 quarters · filed 2022-10-28 | 182.62M shares 10-Q · filed 2022-10-28 | 182.32M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | 182.84M shares 10-Q · filed 2022-08-04 | 182.31M shares 10-Q · filed 2022-08-04 | 182.02M shares derived: average of 3 quarters · filed 2023-02-27 | 181.80M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | 181.77M shares 10-Q · filed 2022-04-29 | 181.61M shares derived: average of 2 quarters · filed 2023-02-27 | 181.45M shares derived: average of 3 quarters · filed 2023-02-27 | 181.27M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | 181.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 181.29M shares derived: average of 2 quarters · filed 2023-02-27 | 181.10M shares derived: average of 3 quarters · filed 2023-02-27 | 180.80M shares 10-K · filed 2023-02-27 |
| 2020-09-30 | 181.14M shares 10-Q · filed 2021-10-29 | 180.94M shares derived: average of 2 quarters · filed 2021-10-29 | 180.59M shares 10-Q · filed 2021-10-29 | 180.33M shares derived: average of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | 180.73M shares 10-Q · filed 2021-07-30 | 180.31M shares 10-Q · filed 2021-07-30 | 180.05M shares derived: average of 3 quarters · filed 2022-02-25 | 179.86M shares derived: average of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | 179.90M shares 10-Q · filed 2021-04-30 | 179.72M shares derived: average of 2 quarters · filed 2022-02-25 | 179.57M shares derived: average of 3 quarters · filed 2022-02-25 | 179.44M shares derived: average of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | 179.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | 179.41M shares derived: average of 2 quarters · filed 2022-02-25 | 179.29M shares derived: average of 3 quarters · filed 2022-02-25 | 179.04M shares 10-K · filed 2022-02-25 |
| 2019-09-30 | 179.29M shares 10-Q · filed 2020-11-06 | 179.17M shares derived: average of 2 quarters · filed 2020-11-06 | 178.87M shares 10-Q · filed 2020-11-06 | 178.64M shares derived: average of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | 179.05M shares 10-Q · filed 2020-08-05 | 178.66M shares 10-Q · filed 2020-08-05 | 178.42M shares derived: average of 3 quarters · filed 2021-02-26 | 178.19M shares derived: average of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | 178.27M shares 10-Q · filed 2020-05-01 | 178.11M shares derived: average of 2 quarters · filed 2021-02-26 | 177.90M shares derived: average of 3 quarters · filed 2021-02-26 | 177.64M shares derived: average of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | 177.94M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | 177.71M shares derived: average of 2 quarters · filed 2021-02-26 | 177.43M shares derived: average of 3 quarters · filed 2021-02-26 | 177.06M shares 10-K · filed 2021-02-26 |
| 2018-09-30 | 177.48M shares 10-Q/A · filed 2019-11-04 | 177.18M shares derived: average of 2 quarters · filed 2019-11-04 | 176.77M shares 10-Q/A · filed 2019-11-04 | 176.45M shares derived: average of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | 176.87M shares 10-Q · filed 2019-08-02 | 176.41M shares 10-Q · filed 2019-08-02 | 176.10M shares derived: average of 3 quarters · filed 2020-02-27 | 175.85M shares derived: average of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | 175.93M shares 10-Q · filed 2019-04-29 | 175.71M shares derived: average of 2 quarters · filed 2020-02-27 | 175.51M shares derived: average of 3 quarters · filed 2020-02-27 | |
| 2017-12-31 | 175.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 175.30M shares derived: average of 2 quarters · filed 2020-02-27 | 174.43M shares 10-K · filed 2020-02-27 | |
| 2017-09-30 | 175.10M shares 10-Q · filed 2017-10-31 | 174.07M shares 10-Q · filed 2017-10-31 | ||
| 2017-03-31 | 172.71M shares 10-Q · filed 2018-04-27 | 172.38M shares derived: average of 2 quarters · filed 2019-02-28 | 170.82M shares derived: average of 3 quarters · filed 2019-02-28 | |
| 2016-12-31 | 172.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | 169.88M shares derived: average of 2 quarters · filed 2019-02-28 | 165.99M shares 10-K · filed 2019-02-28 | |
| 2016-09-30 | 167.71M shares 10-Q · filed 2017-10-31 | 163.96M shares 10-Q · filed 2017-10-31 | ||
| 2015-12-31 | 161.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | 161.02M shares derived: average of 2 quarters · filed 2018-02-26 | 160.82M shares derived: average of 3 quarters · filed 2018-02-26 | 160.03M shares 10-K · filed 2018-02-26 |
| 2015-09-30 | 160.89M shares 10-Q · filed 2016-11-03 | 160.65M shares derived: average of 2 quarters · filed 2016-11-03 | 159.65M shares 10-Q · filed 2016-11-03 | 156.78M shares derived: average of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | 160.41M shares 10-Q · filed 2015-08-05 | 159.02M shares 10-Q · filed 2015-08-05 | 155.41M shares derived: average of 3 quarters · filed 2017-02-27 | 153.31M shares derived: average of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | 157.61M shares 10-Q · filed 2015-05-05 | 152.92M shares derived: average of 2 quarters · filed 2017-02-27 | 150.95M shares derived: average of 3 quarters · filed 2017-02-27 | 149.74M shares derived: average of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | 148.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | 147.62M shares derived: average of 2 quarters · filed 2017-02-27 | 147.12M shares derived: average of 3 quarters · filed 2017-02-27 | 146.35M shares 10-K · filed 2017-02-27 |
| 2014-09-30 | 147.02M shares 10-Q · filed 2015-11-02 | 146.57M shares derived: average of 2 quarters · filed 2015-11-02 | 145.72M shares 10-Q · filed 2015-11-02 | |
| 2014-06-30 | 146.12M shares 10-Q · filed 2015-08-05 | 145.07M shares 10-Q · filed 2015-08-05 | ||
| 2014-03-31 | 143.98M shares 10-Q · filed 2015-05-05 | |||
| 2013-09-30 | 140.80M shares 10-Q · filed 2014-10-28 | 140.10M shares derived: average of 2 quarters · filed 2014-10-28 | 136.10M shares 10-Q · filed 2014-10-28 | |
| 2013-06-30 | 139.40M shares 10-Q · filed 2014-07-31 | 133.72M shares 10-Q · filed 2014-07-31 | ||
| 2013-03-31 | 127.97M shares 10-Q · filed 2014-05-02 | |||
| 2012-12-31 | 120.27M shares 10-K · filed 2013-02-26 | |||
| 2012-06-30 | 117.91M shares 10-Q · filed 2013-07-29 | 116.50M shares 10-Q · filed 2013-07-29 | 115.80M shares derived: average of 3 quarters · filed 2013-07-29 | 114.92M shares derived: average of 4 quarters · filed 2013-07-29 |
| 2012-03-31 | 115.07M shares 10-Q · filed 2012-04-30 | 114.74M shares derived: average of 2 quarters · filed 2013-02-26 | 113.92M shares derived: average of 3 quarters · filed 2013-02-26 | 113.22M shares derived: average of 4 quarters · filed 2013-02-26 |
| 2011-12-31 | 114.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | 113.35M shares derived: average of 2 quarters · filed 2013-02-26 | 112.61M shares derived: average of 3 quarters · filed 2013-02-26 | 112.12M shares 10-K · filed 2013-02-26 |
| 2011-09-30 | 112.29M shares 10-Q · filed 2011-10-31 | 111.70M shares derived: average of 2 quarters · filed 2011-10-31 | 111.36M shares 10-Q · filed 2011-10-31 | 110.36M shares derived: average of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | 111.11M shares 10-Q · filed 2011-08-01 | 110.88M shares 10-Q · filed 2011-08-01 | 109.72M shares derived: average of 3 quarters · filed 2013-02-26 | 107.82M shares derived: average of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | 110.65M shares 10-Q · filed 2012-04-30 | 109.02M shares derived: average of 2 quarters · filed 2013-02-26 | 106.72M shares derived: average of 3 quarters · filed 2013-02-26 | 105.47M shares derived: average of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | 107.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | 104.75M shares derived: average of 2 quarters · filed 2013-02-26 | 103.74M shares derived: average of 3 quarters · filed 2013-02-26 | 103.09M shares 10-K · filed 2013-02-26 |
| 2010-09-30 | 102.11M shares 10-Q · filed 2011-10-31 | 101.91M shares derived: average of 2 quarters · filed 2011-10-31 | 101.66M shares 10-Q · filed 2011-10-31 | 101.44M shares derived: average of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | 101.71M shares 10-Q · filed 2011-08-01 | 101.43M shares 10-Q · filed 2011-08-01 | 101.22M shares derived: average of 3 quarters · filed 2012-02-22 | 100.99M shares derived: average of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | 101.14M shares 10-Q · filed 2011-04-29 | 100.97M shares derived: average of 2 quarters · filed 2012-02-22 | 100.75M shares derived: average of 3 quarters · filed 2012-02-22 | 100.58M shares derived: average of 4 quarters · filed 2012-02-22 |
| 2009-12-31 | 100.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | 100.56M shares derived: average of 2 quarters · filed 2012-02-22 | 100.40M shares derived: average of 3 quarters · filed 2012-02-22 | 100.27M shares 10-K · filed 2012-02-22 |
| 2009-09-30 | 100.33M shares 10-Q · filed 2010-10-29 | 100.20M shares derived: average of 2 quarters · filed 2010-10-29 | 100.10M shares 10-Q · filed 2010-10-29 | |
| 2009-06-30 | 100.06M shares 10-Q · filed 2010-08-04 | 99.98M shares 10-Q · filed 2010-08-04 | ||
| 2008-12-31 | 98.97M shares 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |